Summary
Overview
Work History
Education
Skills
Affiliations
Timeline
Generic
Bharati Shivalkar

Bharati Shivalkar

Meise

Summary

Long track academic profile cardiologist championing early diagnosis with focus on improved patient outcomes and prevention. Vested interest in innovative digital technology and AI. Committed to patient empowerment. Passionate about women's heart health, health literacy and diversity. Industry leadership roles impacting more patient lives than before. Lead strategic, transformational changes for medical affairs with a future-proof long-term vision whilst continuously championing patient centric approaches and academic alliances. Conceptualized strategic and unique global educational initiatives and lead cross-functional teams to execute these initiatives for early diagnosis in rare cardiology. Inspired and inspiring, compassionate and resilient leader with a lightspeed growth mindset.

Overview

23
23
years of professional experience

Work History

Senior Medical Director Rare Cardiology, GMA

Pfizer
07.2023 - 07.2024
  • Conceptualized strategic, unique global educational initiatives and lead cross-functional teams to execute these initiatives for early diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM)
  • Delivered 7 highly impactful global educational programs.
  • Advised large markets on implementing local programs
  • Initiating, advising, and delivering on underdiagnosis of women in ATTR-CM in close-knit GMA and XFT partnerships.
  • Collaboration with WomenAsOne (CLIMB2024) for upskilling female cardiologists including underdiagnosis in women
  • Continued long standing collaboration with the European Society of Cardiology and its affiliated associations (EACVI) and working groups, to co-create educational initiatives and maintain trusting partnerships.

Country Medical Director, BeLux

Pfizer
Brussels
01.2019 - 06.2023
  • Shared accountability for Pfizer BeLux organization with country the general manager before, during the Covid-19 pandemic, and later
  • Lead cross therapeutic area medical affairs teams through strategic transformation into an agile and future-proof one-medical organization
  • Pioneered the BeLux RWE-COE, in 2020 within the international developed markets
  • Active WG member representing industry (& Pfizer) to obtain recognition of Pharmaceutical Medicine as a specialty in Belgium
  • Representing Pfizer in the Health-Science-Technology group (with J&J, GSK & UCB) in the Govt.-initiated R&D Biopharma Hub WG on clinical trials
  • Set up innovative collaboration (LynXcare) to facilitate RWE collaboration between hospitals and lifesciences in the field of Oncology, Cardiology and Rare Disease; using AI and NLP to unlock structured and unstructured clinical data to create federated clinical data warehouses
  • Strong external representation/engagement, representing Pfizer in leadership role in the Industry association, building bridges with academia, scientific organizations, patient advocacy groups, and other important stakeholders.

Director of Cardiac Imaging, Professor of Cardiology

Antwerp University Hospital, University of Antwerp
01.2002 - 10.2018
  • Professor of Cardiology with full clinical program, teaching and research assignments
  • Director of Cardiac Imaging with special interest in AI and 3D-technology, perfusion imaging, women's heart health including HFpEF and prevention
  • Extensive basic and clinical research experience
  • Mentor or supervisor of PhD and Master students (4 PhD and 27 Master students)
  • International research collaborations (Charité, Berlin, Germany; Royal Brompton, London, UK; Radboud University, Nijmegen, Netherlands; Mayo Clinic, Rochester, USA)
  • Initiated several innovative, future-proof programs, including the first extensive stress echo program, the first collaborative Cardiac-CT program, and the first Women's Heart Health Clinic in Belgium.
  • Contributed extensively to national cardiac imaging teaching courses organized by the Belgian Working Group on Non-Invasive Cardiac Imaging
  • Author of well over 50 peer-reviewed papers.
  • Reviewer for international journals.
  • Abstract grader and chairperson for the annual European Society of Cardiology Scientific Sessions.

Education

Post Doc Faculty Supported By The Fulbright Scholarship & NIH-grant ((1R01-HL-65704; PI: Dr. S Kaul) - Chronic Myocardial Ischemia

University of Virginia
Charlottesville, Virginia, USA
12-2001

USMLE Steps 1 & 2 - Medicine

United States licensing exams
08-2000

Cardiologist - Internal Medicine & Cardiology

KU Leuven
Leuven, Belgium
06-1999

Ph.D. - Cardiology

KU Leuven
Leuven, Belgium
06-1998

M.D. - Medicine Graduated With Distinction

University Of Antwerp
Antwerp, Belgium
06-1990

11 'Ordinary' Levels & 4 'Advanced' Levels - Sciences & Maths

Wanstead High School
London
06-1982

Skills

  • Excellent Communicator & Networker
  • Scientific and deeply analytical
  • Inspiring leadership
  • Cross functional leadership
  • Compassionate team player
  • Public speaking
  • Strategic planning
  • Creative pioneer
  • Clinical leadership
  • Direct patient care

__________________________

Hobbies

* yoga

* meditation

* brain health & longevity

* cooking

* interior decorating

* traveling

* reading

__________________________

Lnguages

English : Native speaker

Dutch : Highly proficient

German : Working knowledge

French : B1

Hindi & Marathi : Working knowledge

Affiliations

1. Member recognition commission of medical specialty

04/2024 -

  • Appointed as member of the medical specialist recognition commission in Belgium to assess requests and grant recognition of the new specialty, ‘Pharmaceutical medicine/clinical pharmacology’. Ongoing activity.

2. Board member FEMale at Aarhus University, Dept. of Public Health, Denmark

02/2023

* FEMale = Finding endometriosis using machine learning. H2020 project with focus on improving diagnosis, prevention and care in endometriosis. The FEMale project is developing a scalable multiomics platform to predictand improve interventions along the continuum of care for people withendometriosis. The project has been presented at the Danish parliament andthe European parliament receiving more recognition. Ongoing activity.

3. Co-chair medical director's platform, Pharma.be, Belgium

10/2021 - 04/2023

* Two-year mandate. Strengthening external representation and value of medical affairs within the industry association (Pharma.be). Building bridges and championing alliances with academia and other strategic stakeholders. Initiated the "Medical Director's Health Talk", an informal networking between the industry, academia and other important stakeholders to address burning topics of mutual interest (egs: RWE generation on Belgian Healthcare landscape; improving CUP & MNP in Belgium; Replacing RCT by RWD for regulatory decision making). Active WG member to obtain recognition of Pharmaceutical Medicine as a specialty in Belgium.

4. EACVI task force member at The European Society of Cardiology, Sophia Antipolis, France

05/2020 -

* European Association of Cardiovascular Imaging (under the auspices of the ESC), special task force to develop guidance on specific imaging and other initiatives including multicentric research projects thereby improving diagnosis, treatment and cardiovascular outcomes in women. Ongoing activity.

5. Member of medical Directror's platform Pharma.be, Belgium

01/2019 - 04/2023

* Joined the industry association as member of the medical director's platform to represent Pfizer. Participation and contribution to various WGs (patientengagement; CUP/MNP - individual medical need; patient support programs; Health data agency).

6. Consultant Cardiologist at Delta (CHIREC) Hospital

11/2018 -

* Part-time activity as consultant cardiologist with increasing focus on Women's heart health and imaging. Ongoing activity.

7. Member of European Institute of Womens Health (EIWH), Dublin

05/2017 -

* Member of the European Institute of Women's Health. Have acted as advisorand contributed to the first European Manifesto on Women's Health, "Healthy Women, Healthy Europe", presented to the European Parliament in October 2018. Ongoing activity.

8. IAHV board member, Belgium

10/2016 -

* The International Association of Human Values (IAHV) offers programs to reduce stress and develop leaders so that human values can flourish in people and communities. The programs enhance clarity of mind, shift attitudes and behaviours to develop leaders and communities that are

resilient, responsible and inspired. The IAHV has supported several people and communities with PTSD, and presently carrying out a much-neededprogram for people from Ukraine. Ongoing activity.

Timeline

Senior Medical Director Rare Cardiology, GMA

Pfizer
07.2023 - 07.2024

Country Medical Director, BeLux

Pfizer
01.2019 - 06.2023

Director of Cardiac Imaging, Professor of Cardiology

Antwerp University Hospital, University of Antwerp
01.2002 - 10.2018

Post Doc Faculty Supported By The Fulbright Scholarship & NIH-grant ((1R01-HL-65704; PI: Dr. S Kaul) - Chronic Myocardial Ischemia

University of Virginia

USMLE Steps 1 & 2 - Medicine

United States licensing exams

Cardiologist - Internal Medicine & Cardiology

KU Leuven

Ph.D. - Cardiology

KU Leuven

M.D. - Medicine Graduated With Distinction

University Of Antwerp

11 'Ordinary' Levels & 4 'Advanced' Levels - Sciences & Maths

Wanstead High School
Bharati Shivalkar